Detalles de la búsqueda
1.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
2.
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03).
Oncologist
; 23(8): 912-918, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523646
3.
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Gastric Cancer
; 20(5): 825-833, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28028664
4.
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.
Future Oncol
; 13(25): 2265-2275, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28976226
5.
[Sequential inhibition of angiogenesis in metastatic colorectal cancer: activity and efficacy of aflibercept]. / Inibizione sequenziale dell'angiogenesi nel carcinoma del colon-retto metastatico: attività ed efficacia di aflibercept in un caso clinico.
Recenti Prog Med
; 106(5): 239e-43e, 2015 May.
Artículo
en Italiano
| MEDLINE | ID: mdl-25994542
6.
Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research.
Future Oncol
; 10(7): 1125-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24947252
7.
Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study.
Invest New Drugs
; 30(5): 1978-83, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21769636
8.
Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients.
Ann Vasc Surg
; 26(8): 1127.e9-1127.e13, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22951064
9.
Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy.
Biomedicines
; 10(5)2022 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35625772
10.
Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity.
Crit Rev Oncol Hematol
; 167: 103501, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34673219
11.
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma?
J Geriatr Oncol
; 12(1): 163-167, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653216
12.
An Italian study on treatment trends and outcomes of patients with stage III pancreatic adenocarcinoma in the gemcitabine era: is it time to change?
Anticancer Drugs
; 21(4): 459-64, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20110805
13.
Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802).
Clin Colorectal Cancer
; 19(2): 109-115, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32089455
14.
Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association.
ESMO Open
; 5(6): e001001, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33262200
15.
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists.
Ecancermedicalscience
; 14: 1046, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32565899
16.
Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials.
Cancers (Basel)
; 11(4)2019 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31022922
17.
Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition.
Clin Colorectal Cancer
; 18(2): 125-132.e2, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30846365
18.
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer.
ESMO Open
; 4(4): e000519, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31555481
19.
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer.
Cancer Chemother Pharmacol
; 84(5): 1089-1096, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31493178
20.
Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneal chemotherapy: state of the art and future prospects.
Surg Oncol
; 16 Suppl 1: S145-8, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18023575